International Journal of Nanomedicine · Nov 10, 2026
Nanotherapeutic Strategies Targeting Senescent Microenvironment for Aging-Related Chronic Diseases
By Ma J, Li X, He Z et al.
DCellular senescence is a central driver of age-related chronic diseases, including neurodegeneration, atherosclerosis, metabolic disorders, and fibrosis. The persistent accumulation of senescent cells and their associated secretory phenotype (SASP) creates a shared microenvironmental basis for disease progression across multiple organ systems. Senolytic and senomorphic strategies targeting senescent cells have shown therapeutic promise, yet their clinical translation remains constrained by insufficient targeting specificity, off-target toxicity, and poor tissue penetration. Nanotechnology-enabled delivery systems offer a programmable approach to overcome these barriers through rationally designed carriers that enable selective recognition of senescent cells, microenvironment-responsive drug release, and enhanced tissue accessibility. This review develops an integrated framework that links nanoplatform design principles to mechanistic intervention categories and disease-specific evidence. We first outline the molecular basis of cellular senescence and its pathological roles in age-related diseases. We then systematically examine four mechanistic dimensions of nanotherapeutic intervention in the senescent microenvironment: redox homeostasis modulation, inflammatory reprogramming, senescent cell clearance, and immune surveillance reactivation. These dimensions target reactive oxygen species, pro-inflammatory cytokines, senescent cells, and immune effector cells, respectively. Representative nanoplatforms applied to neurodegenerative, cardiovascular, metabolic, musculoskeletal, and fibrotic diseases are discussed. We further analyze key translational challenges, including senescent cell heterogeneity, impaired drug delivery in aged tissues, and regulatory uncertainty. Finally, we discuss emerging directions in precision rejuvenation, offering a conceptual framework for the next generation of senescence-targeted nanotherapies.
doi.org/10.2147/ijn.s654376Open accessPubMed 43034621Interventions